Psychotherapy Via Texts Can Be Just as Effective

Follow Drugslib on

Medically reviewed by Drugs.com.

By Ernie Mundell HealthDay Reporter

TUESDAY, July 23, 2024 -- Folks with depression who got therapy via text or voice messages fared just as well as those who got weekly video-based telemedicine sessions with a therapist, a new trial has found.

The findings "suggest that psychotherapy delivered via text messages may be a viable alternative to face-to-face or videoconferencing delivery and may allow for more immediate on-demand care," in a time when it's often tough for people to access mental health care, the study authors wrote.

The trial was funded by the U.S. National Institute of Mental Health and published July 19 in the journal Psychiatric Services.

The shutdown of traditional in-office services during the pandemic threw the spotlight on telemedicine as a means of delivering psychiatric care.

But are face-to-face video sessions the only effective way to deliver telemedicine?

In the new study, 215 adults with depression received 12 weeks of telemedicine care from a digital mental health care company called Talkspace (the company played no role in funding the study).

Half of the patients received weekly standard videoconference sessions with a therapist for 30 to 45 minutes.

The other half received psychotherapy delivered via voice or text messages, where patients could interact with the therapist whenever and how often they wanted.

At the halfway point (six weeks), roughly the same amount of patients -- 28 patients receiving message-based therapy and 27 receiving videoconferencing therapy -- showed "significant symptom improvements," according to a team led by Patricia Areán. She conducted the research while at the University of Washington.

"Significant" improvement in depression was defined as at least a 50% decline in scores on a standard questionnaire aimed at gauging mental health.

Folks who had failed to reach that goal by six weeks were switched to another six weeks of either weekly videoconferencing sessions plus message-based therapy, or monthly videoconferencing plus message-based therapy.

Overall, Areán's team found no real differences by the end of the 12-week study in outcomes for people who got videoconference therapy or therapy vis text/voice messaging. Patients in each group showed similar improvements in anxiety and overall functioning.

There was one major difference, however: Folks who were given the message-based therapy stuck with it an average of 7.8 weeks, much longer than the average 4.9 weeks observed among the videoconferencing group.

All of the findings "are particularly important, given the challenges that many people have in accessing traditional psychotherapy," the researchers wrote in a journal news release.

Areán recently moved from her position at the University of Washington to become director of the National Institute of Mental Health’s Division of Services and Intervention Research.

Sources

  • American Psychiatric Association, news release, July 19, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-07-23 21:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords